Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases

Tofacitinib (TFB), a Janus kinase inhibitor, has shown excellent success off-label in treating various dermatological diseases, especially alopecia areata (AA). However, TFB’s safe and targeted delivery into hair follicles (HFs) is highly desirable due to its systemic adverse effects. Nanoparticles...

Descripción completa

Detalles Bibliográficos
Autores principales: Christmann, Rebekka, Ho, Duy-Khiet, Wilzopolski, Jenny, Lee, Sangeun, Koch, Marcus, Loretz, Brigitta, Vogt, Thomas, Bäumer, Wolfgang, Schaefer, Ulrich F., Lehr, Claus-Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760822/
https://www.ncbi.nlm.nih.gov/pubmed/33255225
http://dx.doi.org/10.3390/pharmaceutics12121131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760822/
https://www.ncbi.nlm.nih.gov/pubmed/33255225
http://dx.doi.org/10.3390/pharmaceutics12121131

Ejemplares similares